Lactate is an energy substrate for rodent cortical neurons and enhances their firing activity

  1. Anastassios Karagiannis
  2. Thierry Gallopin
  3. Alexandre Lacroix
  4. Fabrice Plaisier
  5. Juliette Piquet
  6. Hélène Geoffroy
  7. Régine Hepp
  8. Jérémie Naudé
  9. Benjamin Le Gac
  10. Richard Egger
  11. Bertrand Lambolez
  12. Dongdong Li
  13. Jean Rossier
  14. Jochen F Staiger
  15. Hiromi Imamura
  16. Susumu Seino
  17. Jochen Roeper
  18. Bruno Cauli  Is a corresponding author
  1. CNRS, INSERM, Sorbonne Université, France
  2. CNRS, ESPCI Paris, France
  3. Goethe University Frankfurt, Germany
  4. Sorbonne Université, INSERM, CNRS, France
  5. Georg-August-University Goettingen, Germany
  6. Kyoto University, Japan
  7. Kobe University Graduate School of Medicine, Japan

Abstract

Glucose is the mandatory fuel for the brain, yet the relative contribution of glucose and lactate for neuronal energy metabolism is unclear. We found that increased lactate, but not glucose concentration, enhances the spiking activity of neurons of the cerebral cortex. Enhanced spiking was dependent on ATP-sensitive potassium (KATP) channels formed with KCNJ11 and ABCC8 subunits, which we show are functionally expressed in most neocortical neuronal types. We also demonstrate the ability of cortical neurons to take-up and metabolize lactate. We further reveal that ATP is produced by cortical neurons largely via oxidative phosphorylation and only modestly by glycolysis. Our data demonstrate that in active neurons, lactate is preferred to glucose as an energy substrate, and that lactate metabolism shapes neuronal activity in the neocortex through KATP channels. Our results highlight the importance of metabolic crosstalk between neurons and astrocytes for brain function.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1 to 6.

Article and author information

Author details

  1. Anastassios Karagiannis

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Thierry Gallopin

    Brain Plasticity Unit, CNRS UMR 8249, CNRS, ESPCI Paris, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Alexandre Lacroix

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabrice Plaisier

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Juliette Piquet

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Hélène Geoffroy

    Brain Plasticity Unit, CNRS UMR 8249, CNRS, ESPCI Paris, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Régine Hepp

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Jérémie Naudé

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5781-6498
  9. Benjamin Le Gac

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Richard Egger

    Institute for Neurophysiology, Goethe University Frankfurt, Frankfurt, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Bertrand Lambolez

    Neuroscience Paris Seine - Institut de Biologie Paris Seine (NPS - IBPS), Sorbonne Université, INSERM, CNRS, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0653-480X
  12. Dongdong Li

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Jean Rossier

    CNRS, INSERM, Sorbonne Université, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1821-2135
  14. Jochen F Staiger

    Institute for Neuroanatomy, Georg-August-University Goettingen, Goettingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  15. Hiromi Imamura

    Graduate School of Biostudies, Kyoto University, Kyoto, Japan
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1896-0443
  16. Susumu Seino

    Kobe University Graduate School of Medicine, Hyogo, Japan
    Competing interests
    The authors declare that no competing interests exist.
  17. Jochen Roeper

    Institute for Neurophysiology, Goethe University Frankfurt, Frankfurt, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2145-8742
  18. Bruno Cauli

    CNRS, INSERM, Sorbonne Université, Paris, France
    For correspondence
    bruno.cauli@upmc.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1471-4621

Funding

Human Frontier Science Program (RGY0070/2007)

  • Bruno Cauli

Agence Nationale de la Recherche (ANR 2011 MALZ 003 01)

  • Bruno Cauli

Fondation pour la Recherche Médicale (FDT20100920106)

  • Anastassios Karagiannis

Fondation pour la Recherche sur Alzheimer

  • Benjamin Le Gac

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Wistar rats, C57BL/6RJ or Kcnj11-/- (B6.129P2-Kcnj11tm1Sse, backcrossed into C57BL6 over six generations) mice were used for all experiments in accordance with French regulations (Code Rural R214/87 to R214/130) and conformed to the ethical guidelines of both the directive 2010/63/EU of the European Parliament and of the Council and the French National Charter on the ethics of animal experimentation. A maximum of 3 rats or 5 mice were housed per cage and single animal housing was avoided. Male rats and mice of both genders were housed on a 12-hour light/dark cycle in a temperature-controlled (21-25{degree sign}C) room and were given food and water ad libitum. Animals were used for experimentation at 13-24 days of age.

Copyright

© 2021, Karagiannis et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,270
    views
  • 562
    downloads
  • 50
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anastassios Karagiannis
  2. Thierry Gallopin
  3. Alexandre Lacroix
  4. Fabrice Plaisier
  5. Juliette Piquet
  6. Hélène Geoffroy
  7. Régine Hepp
  8. Jérémie Naudé
  9. Benjamin Le Gac
  10. Richard Egger
  11. Bertrand Lambolez
  12. Dongdong Li
  13. Jean Rossier
  14. Jochen F Staiger
  15. Hiromi Imamura
  16. Susumu Seino
  17. Jochen Roeper
  18. Bruno Cauli
(2021)
Lactate is an energy substrate for rodent cortical neurons and enhances their firing activity
eLife 10:e71424.
https://doi.org/10.7554/eLife.71424

Share this article

https://doi.org/10.7554/eLife.71424

Further reading

    1. Neuroscience
    Ernie Yulyaningsih, Jung H Suh ... Pascal E Sanchez
    Research Article

    The integrated stress response (ISR) is a conserved pathway in eukaryotic cells that is activated in response to multiple sources of cellular stress. Although acute activation of this pathway restores cellular homeostasis, intense or prolonged ISR activation perturbs cell function and may contribute to neurodegeneration. DNL343 is an investigational CNS-penetrant small-molecule ISR inhibitor designed to activate the eukaryotic initiation factor 2B (eIF2B) and suppress aberrant ISR activation. DNL343 reduced CNS ISR activity and neurodegeneration in a dose-dependent manner in two established in vivo models – the optic nerve crush injury and an eIF2B loss of function (LOF) mutant – demonstrating neuroprotection in both and preventing motor dysfunction in the LOF mutant mouse. Treatment with DNL343 at a late stage of disease in the LOF model reversed elevation in plasma biomarkers of neuroinflammation and neurodegeneration and prevented premature mortality. Several proteins and metabolites that are dysregulated in the LOF mouse brains were normalized by DNL343 treatment, and this response is detectable in human biofluids. Several of these biomarkers show differential levels in CSF and plasma from patients with vanishing white matter disease (VWMD), a neurodegenerative disease that is driven by eIF2B LOF and chronic ISR activation, supporting their potential translational relevance. This study demonstrates that DNL343 is a brain-penetrant ISR inhibitor capable of attenuating neurodegeneration in mouse models and identifies several biomarker candidates that may be used to assess treatment responses in the clinic.

    1. Neuroscience
    Stefan Passlick, Ghanim Ullah, Christian Henneberger
    Research Article

    Ischemia leads to a severe dysregulation of glutamate homeostasis and excitotoxic cell damage in the brain. Shorter episodes of energy depletion, for instance during peri-infarct depolarizations, can also acutely perturb glutamate signaling. It is less clear if such episodes of metabolic failure also have persistent effects on glutamate signaling and how the relevant mechanisms such as glutamate release and uptake are differentially affected. We modeled acute and transient metabolic failure by using a chemical ischemia protocol and analyzed its effect on glutamatergic synaptic transmission and extracellular glutamate signals by electrophysiology and multiphoton imaging, respectively, in the mouse hippocampus. Our experiments uncover a duration-dependent bidirectional dysregulation of glutamate signaling. Whereas short chemical ischemia induces a lasting potentiation of presynaptic glutamate release and synaptic transmission, longer episodes result in a persistent postsynaptic failure of synaptic transmission. We also observed unexpected differences in the vulnerability of the investigated cellular mechanisms. Axonal action potential firing and glutamate uptake were surprisingly resilient compared to postsynaptic cells, which overall were most vulnerable to acute and transient metabolic stress. We conclude that short perturbations of energy supply lead to a lasting potentiation of synaptic glutamate release, which may increase glutamate excitotoxicity well beyond the metabolic incident.